[The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].

Author: AsamotoH, FujiiH, KawaguchiH, KawakamiA, OzawaY, SawanoT, TsutsumiT

Paper Details 
Original Abstract of the Article :
We treated 34 primary lung cancer patients with chemotherapy of cisplatin and etoposide. There were 2 cases of CR (15%) and 8 cases of PR (61%) out of 13 cases of small cell lung cancer. No case of CR and one case of PR (5%) were obtained out of 21 cases of non-small cell cancer. Side effects were l...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1851407

データ提供:米国国立医学図書館(NLM)

Evaluating the Efficacy and Side Effects of Chemotherapy for Primary Lung Cancer

Lung cancer is a formidable foe in the medical landscape. This study investigates the efficacy and side effects of a chemotherapy regimen combining cisplatin and etoposide in treating primary lung cancer. The authors present the results of their treatment experience, providing valuable insights into the effectiveness and potential risks of this regimen.

Navigating the Desert of Lung Cancer Treatment

The study found that this chemotherapy regimen was particularly effective in treating small cell lung cancer, with a significant response rate. However, it also highlights the potential for serious side effects, including leukopenia, kidney dysfunction, and cardiovascular complications. The authors emphasize the importance of careful patient selection and monitoring during treatment.

A Balancing Act: Weighing the Benefits and Risks of Chemotherapy

This research provides a glimpse into the complexities of lung cancer treatment. It underscores the importance of a careful assessment of the benefits and risks of chemotherapy, taking into account the individual patient's condition and overall health. It's like navigating a treacherous desert, where knowledge is essential for making informed decisions and achieving the best possible outcomes.

Dr. Camel's Conclusion

This study sheds light on the efficacy and safety of a specific chemotherapy regimen for primary lung cancer. The findings emphasize the importance of a comprehensive understanding of the benefits and risks of treatment, highlighting the need for individualized approaches to maximize efficacy and minimize adverse effects.

Date :
  1. Date Completed 1991-06-12
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1851407

DOI: Digital Object Identifier

1851407

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.